Want to see GB:EMVC full AI Analyst Report?
EMVC Stock Chart & Stats
53.50 p
0.00 p(0.00%)
At close: 4:00 PM EDT
53.50 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range40.00 p - 62.00 p
Previous CloseN/A
Volume9.91K
Average Volume (3M)31.99K
Market Cap
£14.96M
Enterprise Value16.47 p
Total Cash (Recent Filing)£511.00K
Total Debt (Recent Filing)£2.60M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding27,967,531
10 Day Avg. Volume35,929
30 Day Avg. Volume31,987
Financial Highlights & Ratios
PEG Ratio5.74
Price to Book (P/B)1.04
Price to Sales (P/S)5.52
P/FCF Ratio-12.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)£3.43M
Bulls Say, Bears Say
Bulls Say
Focused Investment Business ModelNetScientific’s core model is durable: sourcing, funding and supporting early‑stage life sciences companies to drive exits and unrealized valuation gains. That long-horizon, portfolio-driven approach aligns incentives with scalable value creation across multiple assets rather than relying on single product sales.
Improving Revenue And Narrowing LossesRevenue growth acceleration and a materially narrowed net loss in 2025 indicate operational progress and trajectory toward breakeven. If sustained, this trend reduces dependence on financing, validates portfolio monetisation or service income, and supports the case for moving from value preservation to value realisation.
Historically Low Leverage And Equity BaseA meaningful equity base and historically low leverage provide structural financial resilience: capacity to fund follow‑on investments, absorb portfolio volatility and support operations during development cycles. This balance-sheet cushion underpins the firm’s ability to execute long-term investment strategies.
Bears Say
Persistent Negative Operating Cash FlowOperating cash flow has been negative each year, leaving the company reliant on external capital or balance-sheet resources to sustain operations and investments. Persistent cash burn creates execution risk, can force dilutive financings, and constrains the firm’s ability to self-fund follow-on support for portfolio companies.
Deep Operating Losses And High Cost BaseSustained negative operating profitability shows the current cost base outpaces revenue scale. Without durable margin improvement or significant revenue expansion, losses will persist, undermining long-term earnings quality and increasing the likelihood that management must curtail activities or seek external financing.
Declining Equity And Rising Debt In 2025A falling equity base combined with rising debt in 2025 weakens financial flexibility. Erosion of net worth reduces the buffer against portfolio markdowns, raises refinancing and covenant risk, and limits capacity to fund new investments without additional capital raises or strategic exits.
NetScientific News
EMVC FAQ
What was NetScientific PLC’s price range in the past 12 months?
NetScientific PLC lowest share price was 40.00 p and its highest was 62.00 p in the past 12 months.
What is NetScientific PLC’s market cap?
NetScientific PLC’s market cap is £14.96M.
When is NetScientific PLC’s upcoming earnings report date?
NetScientific PLC’s upcoming earnings report date is Sep 24, 2026 which is in 49 days.
How were NetScientific PLC’s earnings last quarter?
Currently, no data Available
Is NetScientific PLC overvalued?
According to Wall Street analysts NetScientific PLC’s price is currently Overvalued.
Does NetScientific PLC pay dividends?
NetScientific PLC does not currently pay dividends.
What is NetScientific PLC’s EPS estimate?
NetScientific PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetScientific PLC have?
NetScientific PLC has 27,967,531 shares outstanding.
What happened to NetScientific PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NetScientific PLC?
Currently, no hedge funds are holding shares in GB:EMVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NetScientific PLC
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors, including sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, and artificial intelligence. The firm also places a strong emphasis on healthcare technologies, particularly digital health, diagnostics, and therapeutics, with a specific focus on ventures that enhance the lives and health outcomes of individuals battling chronic illnesses. Within digital health, core interests lie in data analytics, advanced wearable devices, and other related technologies. Geographically, EMV Capital seeks opportunities within developed European markets, including its home base in the United Kingdom, as well as the United States. While typical investment sizes reach up to £15 million (approximately $20.32 million), the firm retains the flexibility to commit larger sums. A strategic preference is to secure a controlling stake in key subsidiary companies, with investments primarily executed via its balance sheet. Established in 2008, EMV Capital plc operates from its headquarters in London, UK, with an additional presence in Beaconsfield.